|
Kissel, J T; McDermott, M P; Mendell, J R et al. (2001) Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57:1434-40
|
|
Sansone, V; Griggs, R C; Moxley 3rd, R T (2000) Hypothyroidism unmasking proximal myotonic myopathy. Neuromuscul Disord 10:165-72
|
|
Orrell, R W; Tawil, R; Forrester, J et al. (1999) Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology 52:1822-6
|
|
Kissel, J T (1999) Facioscapulohumeral dystrophy. Semin Neurol 19:35-43
|
|
Kissel, J T; McDermott, M P; Natarajan, R et al. (1998) Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 50:1402-6
|
|
(1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group. Neurology 48:38-46
|
|
Sansone, V; Griggs, R C; Meola, G et al. (1997) Andersen's syndrome: a distinct periodic paralysis. Ann Neurol 42:305-12
|
|
Tawil, R; McDermott, M P; Pandya, S et al. (1997) A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 48:46-9
|
|
Tawil, R; Forrester, J; Griggs, R C et al. (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744-8
|
|
MOxley 3rd, R T (1996) Proximal myotonic myopathy: mini-review of a recently delineated clinical disorder. Neuromuscul Disord 6:87-93
|
Showing the most recent 10 out of 36 publications
